What Happened?
San Mateo, -based Kronos-Bio Resigned Barbara Kosacz as Chief Operating Officer and General Counsel
About the Company
Kronos Bio is clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Our proprietary product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks (TRNs) through which they drive oncogenic activity.
About the Person
Barbara Kosacz is Chief Operating Officer and General Counsel at Kronos Bio. Previously, Barbara held various senior legal leadership roles in the industry.
Info Source
News
Short Profile